7 studies found for:    16514137 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta
Condition: Uterine Cervical Cancer
Intervention:
2 Active, not recruiting Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Dasatinib
3 Active, not recruiting Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
Conditions: Esophageal Cancer;   Stomach Cancer;   Pancreatic Cancer
Intervention:
4 Terminated MRI of the Liver With Eovist
Condition: Hepatocellular Carcinoma
Intervention:
5 Terminated A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer
Condition: Human Mammary Carcinoma
Intervention: Drug: AEG35156
6 Recruiting Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Taxol (paclitaxel);   Procedure: Radiotherapy;   Drug: Carboplatin;   Drug: Gemcitabine
7 Completed Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Bevacizumab

Indicates status has not been verified in more than two years